Answerthink's pre-configured EzLifeSciences solutions are designed specifically to help midsize companies streamline new product development, automate manufacture reporting, and meet regulatory compliance requirements. LORENZ's solutions are geared specifically for submission assembly, review, publishing, validation and management for regulated environments within the life sciences industry as well as supporting the FDA mandate to submit electronically by the end of 2007.
"We are delighted to be able to tap into Answerthink's North American sales and service infrastructure, as well as their unrivaled SAP solution and deployment knowledge in the Life Sciences industry," said Wolfgang Witzel, President of LORENZ Life Sciences Group.
"This is a welcome confirmation of the global reputation we have acquired since 1989 in the field of submission management," added Mr. Witzel, stating that "the solutions we have provided to our customers and the results they have achieved are indeed - best practice."
According to Answerthink SAP Solutions Group Managing Director John McGrath, "We're delighted to be working with LORENZ. Our EzLifeSciences solutions are providing superior value for growing, innovative customers. LORENZ has successfully developed purpose-built solutions that can be integrated at ease which will only enhance our offerings to this industry."
Answerthink, Inc. (www.answerthink.com) is a leading business and technology consulting firm that ena bles companies to achieve world-class business performance. By leveraging the comprehensive database of The Hackett Group, Answerthink's business and technology solutions help clients significantly improve performance and maximize returns on technology investments. Capabilities include benchmarking, business transformation, business applications, business intelligence, and offshore application development and support. Founded in 1997, Answerthink has offices throughout the United States and in Europe and Asia. Answerthink was named the SAP 2006 SME Partner of the Year.
About LORENZ Life Sciences Group
LORENZ Life Sciences Group (www.lorenz.cc) develops and markets software solutions for the Life Sciences market. LORENZ's solutions are geared specifically for submission assembly, review, publishing, validation and management. As the number one supplier of submission management systems in the world for US, European and Japanese submissions, LORENZ is currently the market leader in producing eCTDs. With over 100 installations in 20 countries, LORENZ has built a reputable customer base.
Copyright (C) 2007 Answerthink, Inc. All rights reserved. Answerthink and EzLifeSciences as well as their respective logos are trademarks or registered trademarks of Answerthink, Inc.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and involve known and unknown risks, uncertainties and other factors that may cause Answerthink's actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statements. Factors that impact such forward-looking statements include, among others, the ability of the alliance or the products, services, or practices mentioned in this release to deliver the desired effect, our ability to effectively integrate acquisitions into our operations, our ability to attract additional business, our ability to effectively market and sell our transformation advisory product offerings and other services, the timing of projects and the potential for contract cancellations by our customers, changes in expectations regarding the information technology industry, our ability to attract and retain skilled employees, possible changes in collections of accounts receivable, risks of competition, price and margin trends, changes in general economic conditions and interest rates as well as other risks detailed in the Company's Annual Report on Form 10-K for the fiscal year ended December 29, 2006 filed with the Securities and Exchange Commission. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.